Nova Patents
AT427740T

Compositions containing both sedative and non-sedative antihistamines

Abstract

A biphasic antihistamine composition in single oral daily dose or in divided doses which comprises: a) an amount of therapeutic effect of sedating antihistamine to inhibit histamine release for a period of 4 to 12 hours, and b) an amount of therapeutic effect non-sedating antihistamine inhibits histamine release over a period of 10 to 20 hours, having a delayed release, the non-sedating antihistamine being released 4 to 10 hours after ingestion.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

18 members in 9 offices

This recordMember, by publication datePriority claim

Priority claims1

Priority claims
DocumentOfficeKindDate
1220201United States of AmericaA

Members18

Family members, oldest first
DocumentOfficeKind
CA2469369A1CanadaA1
WO03049680A2World Intellectual Property Organization (WIPO)A2
AU2002360462A1AustraliaA1
AU2002360462A8AustraliaA8
US2003130263A1United States of AmericaA1
WO03049680A3World Intellectual Property Organization (WIPO)A3
EP1461015A2European Patent Office (EPO)A2
US6827946B2United States of AmericaB2
US2005069580A1United States of AmericaA1
JP2005511711AJapanA
EP1461015A4European Patent Office (EPO)A4
CA2469369CCanadaC
EP1461015B1European Patent Office (EPO)B1
AT427740TThis recordAustriaT
ATE427740T1AustriaT1
DE60231911D1GermanyD1
US7585520B2United States of AmericaB2
ES2333308T3SpainT3